Fundz

Love Pharma Inc. Announces Closing Of Financing

PRIVATEMay 06, 2022

Round Type

Funding Round

VancouverHealth CareFood And Beverage

Description

VANCOUVER, BC / May 6, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it has completed the second tranche of a non-brokered private placement. The Company accepted subscriptions for 2,375,000 units at a price of $0.02 per unit, for gross proceeds of $47,500. Each unit consists of one common share and one common share purchase warrant

Who else raised in Food And Beverage and Health Care around the same time

Companies in the same sectors as Love Pharma that raised within 45 days of this round, from Fundz verified event records.

  • UPSIDE Foods raised $400M on May 5, 2022.
  • UPSIDE Foods raised $400M (Series C) on April 21, 2022.
  • Sun Life Financial raised $2M (Seed) on April 18, 2022.
  • The Valens Company raised an undisclosed amount (Funding Round) on April 5, 2022.
  • Flow Control Holdings raised an undisclosed amount (Private Equity) on April 5, 2022.
  • Astaria Global raised $8M (Seed) on June 20, 2022.

Who to call at Love Pharma, and when

A new round usually means Love Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Love Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Love Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Love Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Love Pharma

Location

Vancouver, Washington, United States

About

With a focus on the global sexual Health and Wellness markets, Love Pharma Inc. (CSE:LUV) (FSE:G1Q0) was founded in 2020, with a mission to bring to market innovative products that enhance sexual health and wellness while providing an improved quality of life. Love Pharma holds exclusive licenses to produce market, package, sell, and distribute patent-protected therapeutic and pharmaceutical products throughout Europe, the United Kingdom, and North America.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Love Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Love Pharma's next move

See what Strategic adds

Love Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.